Stock Scorecard



Stock Summary for Smith & Nephew plc (SNN) - $35.73 as of 10/8/2025 4:43:22 PM EST

Total Score

14 out of 30

Safety Score

47 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for SNN

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SNN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SNN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SNN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SNN (47 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 4
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 5
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for SNN

SNN or SYK: Which Is the Better Value Stock Right Now? 10/8/2025 3:40:00 PM
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention 10/3/2025 3:53:00 PM
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty 10/1/2025 5:00:00 PM
Should Value Investors Buy Smith & Nephew SNATS ( SNN ) Stock? 9/25/2025 1:40:00 PM
SNN vs. SYK: Which Stock Is the Better Value Option? 9/22/2025 3:40:00 PM
Companies' legal teams feel the AI spark 9/19/2025 4:00:00 AM
Smith & Nephew ( SNN ) Upgraded to Buy: What Does It Mean for the Stock? 9/15/2025 4:00:00 PM
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant 9/11/2025 12:00:00 PM
What Does the Market Think About Smith & Nephew? - Smith & Nephew ( NYSE:SNN ) 9/3/2025 8:00:00 PM
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System 9/3/2025 2:16:00 PM

Financial Details for SNN

Company Overview

Ticker SNN
Company Name Smith & Nephew plc
Country USA
Description Smith & Nephew plc (SNN) is a leading global medical technology company specializing in the development, manufacturing, and marketing of advanced medical devices across various sectors, including orthopedics, advanced wound management, and sports medicine. Headquartered in Watford, United Kingdom, Smith & Nephew leverages innovative technologies to enhance patient outcomes and drive efficiency in healthcare. With a strong commitment to research and development, the company continuously seeks to bring pioneering products to market, catering to healthcare professionals and patients worldwide.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 6/30/2025
Next Earnings Date 11/6/2025

Stock Price History

Last Day Price 35.73
Price 4 Years Ago 31.06
Last Day Price Updated 10/8/2025 4:43:22 PM EST
Last Day Volume 386,264
Average Daily Volume 651,480
52-Week High 38.47
52-Week Low 23.11
Last Price to 52 Week Low 54.61%

Valuation Measures

Trailing PE 32.06
Industry PE 44.24
Sector PE 41.70
5-Year Average PE 49.49
Free Cash Flow Ratio 22.47
Industry Free Cash Flow Ratio 37.96
Sector Free Cash Flow Ratio 30.25
Current Ratio Most Recent Quarter 3.00
Total Cash Per Share 1.59
Book Value Per Share Most Recent Quarter 6.33
Price to Book Ratio 2.80
Industry Price to Book Ratio 3.99
Sector Price to Book Ratio 32.02
Price to Sales Ratio Twelve Trailing Months 2.60
Industry Price to Sales Ratio Twelve Trailing Months 4.50
Sector Price to Sales Ratio Twelve Trailing Months 20.22
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 424,263,000
Market Capitalization 15,158,916,990
Institutional Ownership 7.90%

Dividends

Ex-Dividend Date 10/3/2025
Previous Dividend Amount 0.4620
Current Dividend Amount 0.3000
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.76
Trailing Annual Dividend Yield 2.13%
Forward Annual Dividend Rate 0.60
Forward Annual Dividend Yield 1.68%
5-Year Dividend Payments Count 10
3-Year Average Dividend Yield 3.01%
5-Year Average Dividend Yield 2.87%
1-Year Dividend Growth Rate Percentage 1.60%
3-Year Dividend Growth Rate Percentage 0.80%
5-Year Dividend Growth Rate Percentage 0.40%
All-Time Dividend Growth Rate Percentage 5.45%
Dividend Payout Ratio 68.04%

Income Statement

Quarterly Earnings Growth YOY 35.90%
Annual Earnings Growth 56.65%
Reported EPS 12 Trailing Months 1.12
Reported EPS Past Year 0.43
Reported EPS Prior Year 0.99
Net Income Twelve Trailing Months 814,645,000
Net Income Past Year 412,000,000
Net Income Prior Year 263,000,000
Quarterly Revenue Growth YOY 4.70%
5-Year Revenue Growth 2.49%
Operating Margin Twelve Trailing Months 14.50%

Balance Sheet

Total Cash Most Recent Quarter 675,409,000
Total Cash Past Year 619,000,000
Total Cash Prior Year 302,000,000
Net Cash Position Most Recent Quarter -2,477,591,000
Net Cash Position Past Year -2,504,000,000
Long Term Debt Past Year 3,123,000,000
Long Term Debt Prior Year 2,175,000,000
Total Debt Most Recent Quarter 3,153,000,000
Equity to Debt Ratio Past Year 0.63
Equity to Debt Ratio Most Recent Quarter 0.64
Total Stockholder Equity Past Year 5,265,000,000
Total Stockholder Equity Prior Year 5,217,000,000
Total Stockholder Equity Most Recent Quarter 5,531,156,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 898,319,000
Free Cash Flow Per Share Twelve Trailing Months 2.12
Free Cash Flow Past Year 606,000,000
Free Cash Flow Prior Year 181,000,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.67
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 10/7/2025 9:42:58 AM EST